The Antiarrhythmic Peptide Analog ZP123 Prevents Atrial Conduction Slowing During Metabolic Stress

200571 citationsJournal Article

Authors

Ketil Haugan · Zealand Pharma (Denmark)

Kristine Boisen Olsen · University of Copenhagen

Line Hartvig · Zealand Pharma (Denmark)

Jørgen S. Petersen · Zealand Pharma (Denmark)

Niels‐Henrik Holstein‐Rathlou · University of Copenhagen

James K. Hennan

Morten Schak Nielsen · University of Copenhagen

Abstract

ZP123 has no effects on atrial conduction during physiological conditions, but it selectively prevents atrial conduction slowing during metabolic stress.

Topics & Keywords

Cardiac electrophysiology and arrhythmias Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Cardiovascular Electrophysiology

Volume 16, Issue 5, pp. 537-545

DOI: 10.1111/j.1540-8167.2005.40687.x

Field-Weighted Citation Impact: 6.04